Skip to main content

Table 2 Effect of BAF on WBC count and differential in peripheral blood

From: Evaluation of in vitro and in vivo anti-inflammatory activity of biologically active phospholipids with anti-neoplastic potential in porcine model

 

WBC (x 106in ml)

Lymphocytes (%)

Neutrophils (%)

Control

Supplemented

Control

Supplemented

Control

Supplemented

Day -14

16.5 ± 2.1

18.5 ± 4.4

66.9 ± 9.7

62.8 ± 15.8

31.2 ± 9.8

35.8 ± 9.9

Day 0

18.0 ± 3.2

20.1 ± 2.5

57.6 ± 7.5

58.8 ± 8.4

39.7 ± 8.1

39.4 ± 8.1

Day 1

24.6 ± 6.3

21.1 ± 6.5

45.2 ± 10.8

47.7 ± 11.9

52.5 ± 11.5

50.0 ± 13.1

Day 3

20.9 ± 6.0

21.5 ± 4.0

50.9 ± 12.9

43.1 ± 8.8

46.7 ± 13.2

55.0 ± 9.2

Day 7

19.2 ± 4.1

15.6 ± 2.7

54.6 ± 16.0

52.9 ± 7.8

42.8 ± 15.9

45.5 ± 8.6

Day 14

15.4 ± 4.4

10.6 ± 1.3

56.3 ± 18.9

64.6 ± 8.0

43.2 ± 19.1

34.4 ± 8.5

  1. Day -14 = beginning of BAF supplementation. Day 0 – App challenge.
  2. Values represent mean ± S.D., n = 6 animals in each group.